documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
42,567 rows where posted_year = 2024 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Supporting & Related Material 27,445
- Other 12,059
- Notice 2,006
- Rule 556
- Proposed Rule 501
posted_year 1
- 2024 · 42,567 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APHIS-2023-0088-0001 | APHIS | Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 | Payment of Indemnity and Compensation for Highly Pathogenic Avian Influenza | Rule | Interim Final Rule | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-03-04T04:59:59Z | 2025-03-14T01:00:15Z | 2024-31384 | 0 | 0 | 0900006486896c83 |
| APHIS-2022-0061-0004 | APHIS | Creation of United States Swine Health Improvement Plan APHIS-2022-0061 | US SHIP Program Standards | Supporting & Related Material | Guidance | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:13:38Z | 0 | 0 | 0900006486888ffb | |||
| APHIS-2022-0061-0001 | APHIS | Creation of United States Swine Health Improvement Plan APHIS-2022-0061 | U.S. Swine Health Improvement Plan | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-04-01T03:59:59Z | 2025-04-02T01:00:43Z | 2024-31386 | 0 | 0 | 0900006486896dc1 |
| APHIS-2023-0088-0004 | APHIS | Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 | Biosecurity Audit Tool | Supporting & Related Material | Supplement | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:16:16Z | 0 | 0 | 090000648688880f | |||
| APHIS-2022-0061-0002 | APHIS | Creation of United States Swine Health Improvement Plan APHIS-2022-0061 | PRA Abstract | Supporting & Related Material | Paperwork Packages | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:13:21Z | 0 | 0 | 0900006486888ffd | |||
| APHIS-2023-0088-0003 | APHIS | Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 | Information Collection Abstract | Supporting & Related Material | Paperwork Packages | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:16:11Z | 0 | 0 | 0900006486888a96 | |||
| APHIS-2023-0088-0002 | APHIS | Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 | Initial Regulatory Flexibility Analysis (Economic Analysis) | Supporting & Related Material | Economic Analysis | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:16:02Z | 0 | 0 | 0900006486888ffa | |||
| APHIS-2022-0061-0003 | APHIS | Creation of United States Swine Health Improvement Plan APHIS-2022-0061 | Initial Economic Analysis | Supporting & Related Material | Economic Analysis | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:13:32Z | 0 | 0 | 0900006486888ffc | |||
| EPA-HQ-OPPT-2024-0501-0001 | EPA | EPA-HQ-OPPT-2024-0501 | Preliminary Lists Identifying Manufacturers Subject to Fee Obligations for Five Chemical Substances Undergoing EPA-Initiated Risk Evaluations Under the Toxic Substances Control Act (TSCA); Determination; Notice of Availability and Request for Comment | Proposed Rule | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-03-04T04:59:59Z | 2025-03-01T02:00:28Z | 2024-30930 | 0 | 0 | 0900006486896ad6 | |
| EPA-HQ-OPPT-2024-0501-0003 | EPA | EPA-HQ-OPPT-2024-0501 | High-Priority Substance Designations Under the Toxic Substances Control Act (TSCA) and Initiation of Risk Evaluation on High-Priority Substances; Notice of Availability, December 2024 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:45:59Z | 0 | 0 | 090000648687c2b9 | |||
| EPA-HQ-OPPT-2024-0501-0007 | EPA | EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, 4,4′-Methylene bis(2-chloroaniline) (MBOCA), CAS #: 101-14-4 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:47:04Z | 0 | 0 | 090000648687c2f9 | |||
| EPA-R09-OAR-2024-0633-0001 | EPA | EPA-R09-OAR-2024-0633 | Receipt of Tribal Minor NSR Permit Application for Ratherford Unit WIP Mud Plant | Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-01T01:53:57Z | 0 | 0 | 09000064868974b8 | |||
| EPA-R09-OW-2023-0623-0104 | EPA | EPA-R09-OW-2023-0623 | R9UIC_CA6_FY22_1.4 Final Permit 12.30.2024 | Other | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-01T01:54:26Z | 0 | 0 | 090000648689624e | |||
| EPA-HQ-OPPT-2024-0501-0004 | EPA | EPA-HQ-OPPT-2024-0501 | Fees for the Administration of the Toxic Substances Control Act Final Rule, October 2018 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:45:46Z | 0 | 0 | 090000648687c2ba | |||
| EPA-HQ-OPPT-2024-0501-0005 | EPA | EPA-HQ-OPPT-2024-0501 | Initiation of Prioritization Under the Toxic Substances Control Act (TSCA); Request for Comment, December 2023 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:47:30Z | 0 | 0 | 090000648687c2bb | |||
| EPA-R09-OAR-2023-0649-0011 | EPA | EPA-R09-OAR-2023-0649 | Air Quality State Implementation Plans; Approvals and Promulgations: California; Feather River Air Quality Management District | Rule | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-02T16:12:57Z | 2024-31396 | 0 | 0 | 0900006486896c3c | ||
| EPA-R09-OW-2023-0623-0106 | EPA | EPA-R09-OW-2023-0623 | R9UIC_CA6_FY22_1.2 Final Permit 12.30.2024 | Other | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-01T01:55:30Z | 0 | 0 | 0900006486896584 | |||
| EPA-HQ-OPPT-2024-0501-0009 | EPA | EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Benzenamine, CAS #: 62-53-3 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:38Z | 0 | 0 | 090000648687c2fb | |||
| EPA-R09-OW-2023-0623-0108 | EPA | EPA-R09-OW-2023-0623 | Notice of final permit decision - CTV I 26R (12.30.24) | Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-01T01:54:09Z | 0 | 0 | 090000648689625d | |||
| EPA-R09-OAR-2024-0632-0001 | EPA | EPA-R09-OAR-2024-0632 | Receipt of Tribal Minor NSR Permit Application for McElmo Creek Unit Area 4 Tank Battery | Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-01T01:53:43Z | 0 | 0 | 09000064868974b6 | |||
| EPA-R09-OW-2023-0623-0105 | EPA | EPA-R09-OW-2023-0623 | R9UIC_CA6_FY22_1.3 Final Permit 12.30.2024 | Other | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-01T01:55:12Z | 0 | 0 | 0900006486896243 | |||
| EPA-HQ-OPPT-2024-0501-0002 | EPA | EPA-HQ-OPPT-2024-0501 | Fees for the Administration of the Toxic Substances Control Act (TSCA) Final Rule, February 2024 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:12Z | 0 | 0 | 090000648687c2b8 | |||
| EPA-HQ-OPPT-2024-0501-0008 | EPA | EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acrylonitrile, CAS #: 107-13-1 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:47:17Z | 0 | 0 | 090000648687c2fa | |||
| EPA-R09-OW-2023-0623-0109 | EPA | EPA-R09-OW-2023-0623 | Response to Comments CTV-I 26R (12.30.24) | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:54:39Z | 0 | 0 | 090000648689625e | ||||
| EPA-HQ-OPPT-2024-0501-0006 | EPA | EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acetaldehyde, CAS #: 75-07-0 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:25Z | 0 | 0 | 090000648687c2f8 | |||
| EPA-R09-OW-2023-0623-0107 | EPA | EPA-R09-OW-2023-0623 | R9UIC_CA6_FY22_1.1 Final Permit 12.30.2024 | Other | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-01-01T01:54:56Z | 0 | 0 | 0900006486896564 | |||
| EPA-HQ-OPPT-2024-0501-0010 | EPA | EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Vinyl Chloride, CAS #: 75-01-4 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:51Z | 0 | 0 | 090000648687c2fc | |||
| FDA-2022-N-2390-0097 | FDA | FDA-2022-N-2390 | Exhibit 208 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:54Z | 0 | 0 | 09000064868a2ef0 | |||
| FDA-2022-N-2390-0128 | FDA | FDA-2022-N-2390 | Exhibit 239 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:26Z | 0 | 0 | 09000064868a2f37 | |||
| FDA-2022-N-2390-0123 | FDA | FDA-2022-N-2390 | Exhibit 234 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:56Z | 0 | 0 | 09000064868a2f32 | |||
| FDA-2022-N-2390-0126 | FDA | FDA-2022-N-2390 | Exhibit 237 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:37Z | 0 | 0 | 09000064868a2f35 | |||
| FDA-2022-N-2390-0090 | FDA | FDA-2022-N-2390 | Exhibit 201 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:04Z | 0 | 0 | 09000064868a2ee9 | |||
| FDA-2022-N-2390-0096 | FDA | FDA-2022-N-2390 | Exhibit 207 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:48Z | 0 | 0 | 09000064868a2eef | |||
| FDA-2022-N-2390-0127 | FDA | FDA-2022-N-2390 | Exhibit 238 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:31Z | 0 | 0 | 09000064868a2f36 | |||
| FDA-2022-N-2390-0088 | FDA | FDA-2022-N-2390 | Exhibit 199 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:52Z | 0 | 0 | 09000064868a3103 | |||
| FDA-2022-N-2390-0103 | FDA | FDA-2022-N-2390 | Exhibit 214 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:27Z | 0 | 0 | 09000064868a2f07 | |||
| FDA-2022-N-2390-0115 | FDA | FDA-2022-N-2390 | Exhibit 226 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:14Z | 0 | 0 | 09000064868a2f1d | |||
| FDA-2022-N-2390-0101 | FDA | FDA-2022-N-2390 | Exhibit 212 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:37Z | 0 | 0 | 09000064868a2f05 | |||
| FDA-2022-N-2390-0107 | FDA | FDA-2022-N-2390 | Exhibit 218 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:05Z | 0 | 0 | 09000064868a2f0b | |||
| FDA-2022-N-2390-0120 | FDA | FDA-2022-N-2390 | Exhibit 231 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:47Z | 0 | 0 | 09000064868a2f2f | |||
| FDA-2024-H-5929-0001 | FDA | FDA-2024-H-5929 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:32:14Z | 0 | 0 | 090000648689709d | ||
| FDA-2000-N-0011-0028 | FDA | Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 | Uniform Compliance Date for Food Labeling Regulations | Rule | Final Rule | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-03-04T04:59:59Z | 2025-03-05T02:00:44Z | 2024-31419 | 0 | 0 | 0900006486896c8a |
| FDA-2024-N-3271-0002 | FDA | FDA-2024-N-3271 | Flamingo Pharmaceuticals Ltd.; Withdrawal of Approval of Two Abbreviated New Drug Applications | Notice | Withdrawal | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:36:36Z | 2024-31360 | 0 | 0 | 0900006486896c82 | |
| FDA-2024-H-5921-0001 | FDA | FDA-2024-H-5921 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T16:08:58Z | 0 | 0 | 090000648689712d | ||
| FDA-2022-N-2390-0105 | FDA | FDA-2022-N-2390 | Exhibit 216 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:18Z | 0 | 0 | 09000064868a2f09 | |||
| FDA-2022-N-2390-0106 | FDA | FDA-2022-N-2390 | Exhibit 217 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:11Z | 0 | 0 | 09000064868a2f0a | |||
| FDA-2022-N-2390-0111 | FDA | FDA-2022-N-2390 | Exhibit 222 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:39Z | 0 | 0 | 09000064868a2f19 | |||
| FDA-2022-N-2390-0113 | FDA | FDA-2022-N-2390 | Exhibit 224 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:26Z | 0 | 0 | 09000064868a2f1b | |||
| FDA-2022-N-2390-0079 | FDA | FDA-2022-N-2390 | Exhibit 190 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:08Z | 0 | 0 | 09000064868a27cf | |||
| FDA-2022-N-2390-0084 | FDA | FDA-2022-N-2390 | Exhibit 195 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:11Z | 0 | 0 | 09000064868a28ff | |||
| FDA-2022-N-2390-0098 | FDA | FDA-2022-N-2390 | Exhibit 209 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:59Z | 0 | 0 | 09000064868a2ef1 | |||
| FDA-2022-N-2390-0074 | FDA | FDA-2022-N-2390 | Index to Exhibits | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:42Z | 0 | 0 | 09000064868a4593 | |||
| FDA-2022-N-2390-0080 | FDA | FDA-2022-N-2390 | Exhibit 191 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:13Z | 0 | 0 | 09000064868a28fb | |||
| FDA-2024-H-5925-0001 | FDA | FDA-2024-H-5925 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:58:24Z | 0 | 0 | 090000648689756a | ||
| FDA-2024-H-5800-0001 | FDA | FDA-2024-H-5800 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:04:04Z | 0 | 0 | 0900006486898448 | ||
| FDA-2024-H-5916-0001 | FDA | FDA-2024-H-5916 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:11:03Z | 0 | 0 | 0900006486898d43 | ||
| FDA-2024-H-5928-0001 | FDA | FDA-2024-H-5928 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:04:26Z | 0 | 0 | 0900006486897071 | ||
| FDA-2024-H-5920-0001 | FDA | FDA-2024-H-5920 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T15:13:15Z | 0 | 0 | 09000064868968ce | ||
| FDA-2024-H-5922-0001 | FDA | FDA-2024-H-5922 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T15:54:19Z | 0 | 0 | 0900006486897104 | ||
| FDA-2024-N-2980-0006 | FDA | FDA-2024-N-2980 | Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products; Reopening of the Comment Period | Notice | Extension of Comment Period | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:48:35Z | 2024-31365 | 0 | 0 | 0900006486896ad4 | |
| FDA-2024-H-5924-0001 | FDA | FDA-2024-H-5924 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:57:26Z | 0 | 0 | 090000648689754d | ||
| FDA-2022-N-2390-0085 | FDA | FDA-2022-N-2390 | Exhibit 196 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:17Z | 0 | 0 | 09000064868a3100 | |||
| FDA-2022-N-2390-0100 | FDA | FDA-2022-N-2390 | Exhibit 211 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:11Z | 0 | 0 | 09000064868a2f04 | |||
| FDA-2022-N-2390-0102 | FDA | FDA-2022-N-2390 | Exhibit 213 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:32Z | 0 | 0 | 09000064868a2f06 | |||
| FDA-2022-N-2390-0104 | FDA | FDA-2022-N-2390 | Exhibit 215 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:23Z | 0 | 0 | 09000064868a2f08 | |||
| FDA-2022-N-2390-0112 | FDA | FDA-2022-N-2390 | Exhibit 223 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:32Z | 0 | 0 | 09000064868a2f1a | |||
| FDA-2022-N-2390-0114 | FDA | FDA-2022-N-2390 | Exhibit 225 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:20Z | 0 | 0 | 09000064868a2f1c | |||
| FDA-2022-N-2390-0117 | FDA | FDA-2022-N-2390 | Exhibit 228 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:03Z | 0 | 0 | 09000064868a2f1f | |||
| FDA-2024-H-5931-0001 | FDA | FDA-2024-H-5931 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:48:56Z | 0 | 0 | 09000064868971c7 | ||
| FDA-2024-H-5917-0001 | FDA | FDA-2024-H-5917 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:11:54Z | 0 | 0 | 0900006486898d49 | ||
| FDA-2022-N-2390-0083 | FDA | FDA-2022-N-2390 | Exhibit 194 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:40Z | 0 | 0 | 09000064868a28fe | |||
| FDA-2022-N-2390-0094 | FDA | FDA-2022-N-2390 | Exhibit 205 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:37Z | 0 | 0 | 09000064868a2eed | |||
| FDA-2022-N-2390-0089 | FDA | FDA-2022-N-2390 | Exhibit 200 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:58Z | 0 | 0 | 09000064868a3104 | |||
| FDA-2022-N-2390-0075 | FDA | FDA-2022-N-2390 | Exhibit 186 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:49Z | 0 | 0 | 09000064868a27cb | |||
| FDA-2022-N-2390-0076 | FDA | FDA-2022-N-2390 | Exhibit 187 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:55Z | 0 | 0 | 09000064868a27cc | |||
| FDA-2022-N-2390-0099 | FDA | FDA-2022-N-2390 | Exhibit 210 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:05Z | 0 | 0 | 09000064868a2ef2 | |||
| FDA-2022-N-2390-0124 | FDA | FDA-2022-N-2390 | Exhibit 235 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:49Z | 0 | 0 | 09000064868a2f33 | |||
| FDA-2022-N-2390-0122 | FDA | FDA-2022-N-2390 | Exhibit 233 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:36Z | 0 | 0 | 09000064868a2f31 | |||
| FDA-2022-N-2390-0109 | FDA | FDA-2022-N-2390 | Exhibit 220 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:53Z | 0 | 0 | 09000064868a2f0d | |||
| FDA-2024-H-5918-0001 | FDA | FDA-2024-H-5918 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:00:47Z | 0 | 0 | 090000648689688b | ||
| FDA-2024-H-5867-0001 | FDA | FDA-2024-H-5867 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:43:58Z | 0 | 0 | 09000064868968a8 | ||
| FDA-2024-N-5830-0001 | FDA | FDA-2024-N-5830 | Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal | Notice | Notice of Renewal | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:00:03Z | 2024-31363 | 0 | 0 | 0900006486896cc5 | |
| FDA-2024-H-5926-0001 | FDA | FDA-2024-H-5926 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:59:14Z | 0 | 0 | 090000648689758c | ||
| FDA-2024-H-5915-0001 | FDA | FDA-2024-H-5915 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:09:09Z | 0 | 0 | 09000064868984fb | ||
| FDA-2024-H-5832-0001 | FDA | FDA-2024-H-5832 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:07:02Z | 0 | 0 | 090000648689844e | ||
| FDA-2022-N-2390-0086 | FDA | FDA-2022-N-2390 | Exhibit 197 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:27Z | 0 | 0 | 09000064868a3101 | |||
| FDA-2022-N-2390-0092 | FDA | FDA-2022-N-2390 | Exhibit 203 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:18Z | 0 | 0 | 09000064868a2eeb | |||
| FDA-2022-N-2390-0095 | FDA | FDA-2022-N-2390 | Exhibit 206 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:43Z | 0 | 0 | 09000064868a2eee | |||
| FDA-2022-N-2390-0129 | FDA | FDA-2022-N-2390 | Exhibit 240 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:19Z | 0 | 0 | 09000064868a2f38 | |||
| FDA-2022-N-2390-0093 | FDA | FDA-2022-N-2390 | Exhibit 204 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:32Z | 0 | 0 | 09000064868a2eec | |||
| FDA-2022-N-2390-0116 | FDA | FDA-2022-N-2390 | Exhibit 227 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:09Z | 0 | 0 | 09000064868a2f1e | |||
| FDA-2022-N-2390-0118 | FDA | FDA-2022-N-2390 | Exhibit 229 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:57Z | 0 | 0 | 09000064868a2f20 | |||
| FDA-2022-N-2390-0110 | FDA | FDA-2022-N-2390 | Exhibit 221 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:47Z | 0 | 0 | 09000064868a2f18 | |||
| FDA-2022-N-2390-0121 | FDA | FDA-2022-N-2390 | Exhibit 232 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:41Z | 0 | 0 | 09000064868a2f30 | |||
| FDA-2024-H-5923-0001 | FDA | FDA-2024-H-5923 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T16:22:10Z | 0 | 0 | 0900006486897134 | ||
| FDA-2024-H-5919-0001 | FDA | FDA-2024-H-5919 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T15:50:42Z | 0 | 0 | 09000064868968fe | ||
| FDA-2024-H-5930-0001 | FDA | FDA-2024-H-5930 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:33:28Z | 0 | 0 | 090000648689751e | ||
| FDA-2024-H-5914-0001 | FDA | FDA-2024-H-5914 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:08:06Z | 0 | 0 | 0900006486898496 | ||
| FDA-2022-N-2390-0078 | FDA | FDA-2022-N-2390 | Exhibit 189 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:07Z | 0 | 0 | 09000064868a27ce | |||
| FDA-2022-N-2390-0091 | FDA | FDA-2022-N-2390 | Exhibit 202 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:10Z | 0 | 0 | 09000064868a2eea |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);